FI20021819A0 - Valmiste alkoholin metabolian tehostamiseksi - Google Patents

Valmiste alkoholin metabolian tehostamiseksi

Info

Publication number
FI20021819A0
FI20021819A0 FI20021819A FI20021819A FI20021819A0 FI 20021819 A0 FI20021819 A0 FI 20021819A0 FI 20021819 A FI20021819 A FI 20021819A FI 20021819 A FI20021819 A FI 20021819A FI 20021819 A0 FI20021819 A0 FI 20021819A0
Authority
FI
Finland
Prior art keywords
alcohol
glyceric acid
complexes
metabolism
nadh
Prior art date
Application number
FI20021819A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Pekka Untamo Heino
Original Assignee
Pekka Untamo Heino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pekka Untamo Heino filed Critical Pekka Untamo Heino
Priority to FI20021819A priority Critical patent/FI20021819A0/fi
Publication of FI20021819A0 publication Critical patent/FI20021819A0/fi
Priority to ES03750763T priority patent/ES2270074T3/es
Priority to PL03374775A priority patent/PL374775A1/xx
Priority to EP03750763A priority patent/EP1562576B1/fr
Priority to CNB2003801014124A priority patent/CN100459975C/zh
Priority to CA002501543A priority patent/CA2501543C/fr
Priority to PCT/FI2003/000757 priority patent/WO2004035040A1/fr
Priority to RU2005113980/15A priority patent/RU2343911C2/ru
Priority to KR1020057006373A priority patent/KR100693628B1/ko
Priority to AU2003268987A priority patent/AU2003268987B2/en
Priority to AT03750763T priority patent/ATE330594T1/de
Priority to JP2004544334A priority patent/JP2006507268A/ja
Priority to DE60306410T priority patent/DE60306410T2/de
Priority to US11/105,022 priority patent/US7666909B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Lubricants (AREA)
FI20021819A 2002-10-14 2002-10-14 Valmiste alkoholin metabolian tehostamiseksi FI20021819A0 (fi)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FI20021819A FI20021819A0 (fi) 2002-10-14 2002-10-14 Valmiste alkoholin metabolian tehostamiseksi
DE60306410T DE60306410T2 (de) 2002-10-14 2003-10-13 Verbesserung des alkoholstoffwechsels
PCT/FI2003/000757 WO2004035040A1 (fr) 2002-10-14 2003-10-13 Amelioration du metabolisme de l'alcool
PL03374775A PL374775A1 (en) 2002-10-14 2003-10-13 Enhancement of alcohol metabolism
EP03750763A EP1562576B1 (fr) 2002-10-14 2003-10-13 Amelioration du metabolisme de l'alcool
CNB2003801014124A CN100459975C (zh) 2002-10-14 2003-10-13 D-甘油酸或其盐用于制备增强酒精代谢的药物制剂的用途
CA002501543A CA2501543C (fr) 2002-10-14 2003-10-13 Amelioration du metabolisme de l'alcool
ES03750763T ES2270074T3 (es) 2002-10-14 2003-10-13 Mejora del metabolismo del alcohol.
RU2005113980/15A RU2343911C2 (ru) 2002-10-14 2003-10-13 Усиление метаболизма алкоголя
KR1020057006373A KR100693628B1 (ko) 2002-10-14 2003-10-13 알코올 대사의 향상
AU2003268987A AU2003268987B2 (en) 2002-10-14 2003-10-13 Enhancement of alcohol metabolism
AT03750763T ATE330594T1 (de) 2002-10-14 2003-10-13 Verbesserung des alkoholstoffwechsels
JP2004544334A JP2006507268A (ja) 2002-10-14 2003-10-13 アルコール代謝の促進
US11/105,022 US7666909B2 (en) 2002-10-14 2005-04-13 Enhancement of alcohol metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20021819A FI20021819A0 (fi) 2002-10-14 2002-10-14 Valmiste alkoholin metabolian tehostamiseksi

Publications (1)

Publication Number Publication Date
FI20021819A0 true FI20021819A0 (fi) 2002-10-14

Family

ID=8564745

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021819A FI20021819A0 (fi) 2002-10-14 2002-10-14 Valmiste alkoholin metabolian tehostamiseksi

Country Status (14)

Country Link
US (1) US7666909B2 (fr)
EP (1) EP1562576B1 (fr)
JP (1) JP2006507268A (fr)
KR (1) KR100693628B1 (fr)
CN (1) CN100459975C (fr)
AT (1) ATE330594T1 (fr)
AU (1) AU2003268987B2 (fr)
CA (1) CA2501543C (fr)
DE (1) DE60306410T2 (fr)
ES (1) ES2270074T3 (fr)
FI (1) FI20021819A0 (fr)
PL (1) PL374775A1 (fr)
RU (1) RU2343911C2 (fr)
WO (1) WO2004035040A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118358A1 (fr) 2005-05-02 2006-11-09 Cj Corporation Composition destinee a prevenir et a traiter la xylostomiase
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
DE102011001768A1 (de) 2011-04-04 2012-10-04 Gunnar Frank Präparat oder Nahrungsergänzungsmittel
US9161957B2 (en) 2012-08-03 2015-10-20 Life Well Lived, Llc Compositions and methods for reducing blood alcohol content
BR112015026884A2 (pt) 2013-04-29 2017-07-25 Chigurupati Tech Private Limited composição de bebida alcoólica para a provisão de proteção hepática sinérgica; processo para a preparação de uma composição de bebida alcoólica; utilização da composição de bebida alcoólica e bebida alcoólica
WO2015036656A2 (fr) 2013-09-13 2015-03-19 Replicon Health Oy Procédé d'amélioration de la production d'énergie et du métabolisme dans des cellules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2936233B2 (ja) * 1990-09-10 1999-08-23 有限会社野々川商事 新規美白化粧料
BR9205870A (pt) * 1991-04-10 1994-09-27 Ruey J Yu Composiçoes compreendendo acidos 2-hidroxicarboxilicos e compostos relacionados e métodos para aliviar sinais de envelhecimento dermatologico.
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection

Also Published As

Publication number Publication date
AU2003268987A1 (en) 2004-05-04
WO2004035040A1 (fr) 2004-04-29
EP1562576A1 (fr) 2005-08-17
US20050182135A1 (en) 2005-08-18
KR100693628B1 (ko) 2007-03-14
PL374775A1 (en) 2005-10-31
ATE330594T1 (de) 2006-07-15
CA2501543C (fr) 2008-08-19
CN1705476A (zh) 2005-12-07
KR20050050671A (ko) 2005-05-31
RU2005113980A (ru) 2006-01-20
CA2501543A1 (fr) 2004-04-29
DE60306410D1 (de) 2006-08-03
US7666909B2 (en) 2010-02-23
CN100459975C (zh) 2009-02-11
EP1562576B1 (fr) 2006-06-21
JP2006507268A (ja) 2006-03-02
ES2270074T3 (es) 2007-04-01
DE60306410T2 (de) 2007-06-14
AU2003268987B2 (en) 2005-11-03
RU2343911C2 (ru) 2009-01-20

Similar Documents

Publication Publication Date Title
CN1049334C (zh) 脂肪酸药剂的新用途
WO2006086108A3 (fr) Utilisation d'inhibiteurs de l'epoxyde hydrolase soluble pour synergiser l'activite d'inhibiteurs de cox et de 5-lox
CN1635864A (zh) 寡糖醛糖酸及在局部表面上的应用
NZ620473A (en) Compositions and methods for lowering triglycerides without raising ldl-c levels
WO2003072111A3 (fr) Acides gras omega-3 utilises pour traiter la depression
WO2006000867B1 (fr) Compositions de traitement par voie topique
JP2005519985A5 (fr)
WO2007047194A3 (fr) Méthodes pour traiter des troubles en rapport avec le mitf
EP3592360A1 (fr) AceFaPC POUR LE TRAITEMENT DES MALADIES ACÉTYLCHOLINE DÉPENDANTES
FI20021819A0 (fi) Valmiste alkoholin metabolian tehostamiseksi
LU83869A1 (fr) Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine
RU2353358C2 (ru) Производные прегабалина для лечения приливов
EA200401052A1 (ru) Стимуляция cpt-1 как средство уменьшения веса
CN113197884A (zh) α-酮丁酸在制备预防和/或治疗非酒精性脂肪肝的药物中的应用
Fisher et al. Liver fat and plasma ethanol are sharply lower in rats fed ethanol in conjunction with high carbohydrate compared with high fat diets
US20150374660A1 (en) Ascorbate Esters of Omega-3 Fatty Acids and Their Formulations and Uses
FR2531632A1 (fr) Produits pharmaceutiques avec action cytostatique, a base d'esters d'acides gras
JP2005132766A (ja) 光動力学的癌治療薬
EP1875906A3 (fr) Utilisation thérapeutique de yessotaxines en tant qu'inhibiteurs de croissance de cellule de tumeur humaine
Kasemset et al. Regulation of Mn-SOD activity in the mouse heart: Glucose effect
Khan-Siddiqui Lysine-carnitine conversion in rat and man
BE897738A (fr) Procede et compositions pour combattre la croissance de tumeurs
KR890000399A (ko) (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
RU2005126992A (ru) Способ комбинированного лечения операбельного рака желудка
Waldman et al. Effects of ultraviolet radiation on eicosanoid metabolism in intact skin